- January 20, 2021
- Posted by: Bastion team
- Category: Markets
This post was originally published on this site
(RTTNews) – Shares of clinical-stage drug discovery company Lixte Biotechnology Holdings, Inc. (LIXT) are rising more than 15% Tuesday morning after the company announced an agreement with cancer research and treatment center, City of Hope to begin Phase 1b study of LB-100 in small cell lung cancer.
The trial will assess the combination of Lixte’s first-in-class protein phosphatase inhibitor LB-100 with a standard regimen for untreated, extensive stage-disease small cell lung cancer (ED-SCLC).
LB-100 will be given in combination with carboplatin, etoposide and atezolizumab, an FDA approved but marginally effective regimen, in previously untreated ED-SCLC.
LIXT, currently at $3.61, has traded in the range of $0.80- $7.86 in the last one year.
Recommended articles
- An ad agency CEO sued Omnicom's DDB, alleging he was 'exploited' to win a $4 billion US Army contract
Hero Group founder and CEO Joe Anthony. Hero GroupAd agency Hero Group sued Omnicom's DDB agency over a $4 billion US Army contract. The suit claims DDB brought on Hero Group to win the contract but n...(read more)
- COMSovereign Holding Corp. Announces Nasdaq Listing and Pricing of $16.0 Million Public Offering
DALLAS, Jan. 21, 2021 /PRNewswire/ -- COMSovereign Holding Corp. (NASDAQ: COMS) ("ComSovereign" or "Company"), a U.S.-based developer of 4G LTE Advanced and 5G Communication Systems and Solutions, tod...(read more)
- Hong Kong Bourse May Extend Thursday's Losses
(RTTNews) - The Hong Kong stock market on Thursday snapped the five-day winning streak in which it had surged more than 1,720 points or 6.2 percent. The Hang Seng Index now rests just above the 29,925...(read more)
- New Research Reveals Bank and Credit Union Plans for Replacing Core Systems in 2021
SCOTTSDALE, Ariz., Jan. 21, 2021 /PRNewswire/ -- Cornerstone Advisors announced today that Steve Wildman, formerly of Next Step and Open Solutions, has joined the firm to head up its Core Transformati...(read more)
- Evolve Announces January 2021 Distributions for Certain Evolve Funds
TORONTO, Jan. 21, 2021 /CNW/ - Evolve Funds Group Inc. ("Evolve") is pleased to announce the distribution amounts per unit (the "Distributions") for certain funds (the "Evolve Funds"), as indicated in...(read more)
Bastion Balance Seoul, Korea.
